Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.4.8EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.4.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FL.4.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.4.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.4.8NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FL.4.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.4.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.4.8NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
FL.4.8NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FL.4.8ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
EG.5.1.18ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
EG.5.1.18ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
EG.5.1.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.5.1.18ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
EG.5.1.18ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
EG.5.1.18ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
EG.5.1.18ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
EG.5.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.5.1.18SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EG.5.1.18SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-18758.6South Korea
EG.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.5.1.18NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EG.5.1.18NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.18NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.5.1.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.18NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.1.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.5.1.18NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EG.5.1.18ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
HK.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
HK.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HK.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
HK.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HK.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
HK.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
HK.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
HK.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
HK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used